Study on Adhesion Properties of Three Different Adhesives
A Single Centre Comparison Study on Adhesion Properties of Three (3) Skin Adhesives on Healthy, Female, Adult Volunteers
1 other identifier
interventional
39
1 country
1
Brief Summary
This clinical investigation is a single centre, double blinded, case control study in healthy adult females. This study will be conducted in private rooms at Gentofte Hospital (Hjerte-medicinsk Forskning, post 835, Kildegårdsvej 28, 2900 Hellerup). The investigation centre will enroll 39 subjects including a 20% drop out within a four (4) months period. The subject will not be enrolled before approval of investigation protocol by the local ethics committee. The subjects need to meet the inclusion and exclusion criteria to be included in this clinical investigation. Each volunteer enrolled in the investigation can only participate once in a procedure. The testing period for each subject will be minimum 72 hours. The principal investigator's qualifications will be verified through his/her CV. The principal investigator is required to be a medical doctor with at least one year's experience in using similar medical adhesives (e.g. by being experienced in using electrodes where medical adhesives are included) and at least one year's experience with clinical research. In addition, the investigator must be trained in GCP before the study is initiated. If any subject withdraws from the study, they will not be replaced as drop-out rate is included in the sample size. Subjects must show up for two sessions, in the first session six adhesives will be placed below the subjects bra. The adhesives will be removed after minimum 72 hours at the second visit. While wearing the adhesives the subjects must keep the investigational area dry. 24, 48 and 72 hours after placement of the adhesives, the subject is asked to completed a questionnaire. The eCRF must be completed for each subject that has signed the Informed consent form (ICF) and enrolled into this clinical investigation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Oct 2019
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 7, 2019
CompletedFirst Submitted
Initial submission to the registry
October 11, 2019
CompletedFirst Posted
Study publicly available on registry
October 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2019
CompletedNovember 19, 2019
November 1, 2019
24 days
October 11, 2019
November 18, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Skin adhesion rating
Rate of adhesion on a 5-point scale (no lift off the skin to deattached and completely off the skin)
Minimum 72 hours after application
Secondary Outcomes (5)
Itch
24, 48 and 72 hours after adsive application
Ease of removal
Minimum 72 hours after application
Pain during removal of adhesive
Minimum 72 hours after application
Rate of skin reaction
Minimum 72 hours after application
Adhesive residue
Minimum 72 hours after application
Study Arms (3)
Adhesive 1
ACTIVE COMPARATORThis arm investigates one type of silicone adhesive (3M2475P) on adult female skin.
Adhesive 2
ACTIVE COMPARATORThis arm investigates one type of silicone adhesive (RX1449P) on adult female skin.
Adhesive 3
ACTIVE COMPARATORThis arm investigates one type of silicone adhesive (PS-1243) on adult female skin.
Interventions
Adhesive will be placed on the subjects skin below the bra. Placement of the adhesive will be randomized.
Eligibility Criteria
You may qualify if:
- Female Healthy Volunteers.
- Age 18 - 40 years old.
- Willing to attend two scheduled visits
- Able to assess itch and adherence at 24h, 48h and 72h.
- Provide written informed consent.
You may not qualify if:
- Non-intact skin barrier (e.g. eczema, rash, cut, scar tissue, wound, etc.).
- History of inflammatory skin diseases (e.g. atopic dermatitis or psoriasis).
- History of contact allergy
- Swimming or engaging in sport activities causing sweat during study peri-od. v. Use of medication (e.g. corticosteroids) which could affect skin reactions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ambu A/Slead
Study Sites (1)
Gentofte Hospital
Hellerup, 2900, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2019
First Posted
October 14, 2019
Study Start
October 7, 2019
Primary Completion
October 31, 2019
Study Completion
October 31, 2019
Last Updated
November 19, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share